✦ LIBER ✦

Viral and host factors that contribute to efficacy of interferon-α2atherapy in patients with chronic hepatitis C

✍ Scribed by Akihiro Matsumoto; Eiji Tanaka; Toshio Suzuki; Hiroyuki Ogata; Kendo Kiyosawa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Viral and Host Factors in Determining Re

✍ Piero L. Almasio; Vito Di Marco; Celestino Bonura; Patrizia Fuschi; Calogero Cam 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 124 KB

Clinical and histologic predictors of re

✍ Nancy P. Lam; Lino J. DeGuzman; David Pitrak; Thomas J. Layden 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 523 KB

Are viral or host factors predictive of

✍ Bruno Roche; Didier Samuel 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 225 KB

Efficacy and safety of pegylated (40-kd)

✍ K.Rajender Reddy; Teresa L. Wright; Paul J. Pockros; Mitchell Shiffman; Gregory 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Early hepatitis C viral RNA decline duri

✍ Min, A.; Jones, J.; Esposito, S.; Lebovics, E.; Klion, F.; Jacobson, I.; Goldman 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Efficacy of pegylated interferon-α2a mon

✍ Tomoyuki Tsunoda; Ayano Inui; Yuri Etani; Yuki Kiyohara; Tokio Sugiura; Koichi I 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB